DexCom (DXCM) PT Raised to $190 at BMO Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $84.11 -0.36%
Rating Summary:
33 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
33 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
BMO Capital analyst Joanne Wuensch raised the price target on DexCom (NASDAQ: DXCM) to $190.00 (from $180.00) while maintaining an Outperform rating.
- story keeps getting better
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aritzia (ATZ:CN) (ATZAF) PT Raised to Cdn$228 at UBS on Strong Growth
- Teva Pharma (TEVA) PT Raised to $52 at Oppenheimer
- Zeta Global Holdings Corp (ZETA) PT Raised to $38 at KeyBanc
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
